Pfizer stresses patient safety during Karnataka investigation into fake drugs
Pfizer said patient safety remains its top priority as authorities investigate fake drugs in Karnataka. The company said it was working closely with officials to resolve outstanding questions and highlighted public-health protection and confidence in the healthcare system. The supplied material does not identify the medicines involved or describe the investigation’s findings.
Pfizer said it was working closely with authorities during an investigation into fake drugs in Karnataka. The company said it continued to cooperate in resolving outstanding questions linked to the probe. Pfizer emphasised that its focus was protecting patients, safeguarding public health and maintaining confidence in the healthcare system.
The supplied material does not specify which products are under examination, how many medicines may be affected, or what authorities have concluded. It also does not provide details of any regulatory or legal action.
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.